Skip to main content
OpenTrials
Completed

NCT Number: NCT07120360

Gender Microagression Psychoeducation

Objective: This study evaluates the effectiveness of the Gender-Based Microaggression Awareness and Prevention Psychoeducation Program, which was designed to enhance awareness of gender-based microaggressions among female university students and to improve their coping skills. The program's impact on gender role attitudes and psychological distress was also examined.

Methods: The research employed a quasi-experimental design with pre-test and post-test measurements. Gender-based microaggressions are defined as subtle but harmful actions or expressions targeting individuals' identities, often perpetrated unconsciously. In particular, gender-based microaggressions perpetuate traditional gender roles, undermine women's autonomy, and negatively affect psychological well-being, constituting invisible barriers in social and professional life.

The psychoeducation program consisted of six modules aiming to increase awareness of microaggressions, develop coping and assertiveness skills, enhance critical thinking regarding gender roles, and reduce gender role stress. The program included theoretical knowledge, experiential learning, assertiveness training, and stress management strategies. A total of 80 students participated, with 31 assigned to the experimental group and 49 to the control group.

Instruments: Data were collected using the Personal Information Form, Ambivalent Sexism Inventory, Female Microaggressions Scale, Depression-Anxiety-Stress Scale (DASS-21), and semi-structured interviews prepared by the researcher.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Van Yuzuncu Yıl University, Van, Tusba, Turkey (Türkiye)

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being a woman,
  • Knowing Turkish,
  • Not having any communication problems (language, hearing, etc.).
  • Being 18 years of age or older,
  • Being willing to participate in the research.

Exclusion criteria

  • Having a mental or physical problem that prevents communication,
  • Being male

Treatment and study plan

Gender-Based Microaggression Awareness and Prevention Psychoeducation Program

Other

The psychoeducation program consisted of six modules aiming to increase awareness of microaggressions, develop coping and assertiveness skills, enhance critical thinking regarding gender roles, and reduce gender role stress. The program included theoretical knowledge, experiential learning, assertiveness training, and stress management strategies.

Primary outcomes

  1. Gender microagressions level

    Time frame: From enrollment to the end of psychoeducation at 6 weeks

    The scale developed by Miyake (2018) aims to measure gender-based microaggressions experienced by women throughout their lives. The scale was developed through a two-phase study and consists of eight thematic factors: sexual objectification; second-class citizenship/assumptions of inferiority; traditional gender roles; denial of sexism; sexist language use; environmental microaggressions; implicit threat to physical safety; and explicit threat to physical safety. Each factor represents a specific form of microaggression, using thematic classifications instead of the typical categories of microassaults, microinsults, or microinvalidations. The scale includes 34 items rated on a 4-point Likert scale (1 = Never, 4 = Often).

  2. Gender Role Attitudes

    Time frame: From enrollment to the end of treatment at 6 weeks

    The Ambivalent Sexism Inventory (ASI) was developed by Glick and Fiske (1996) to assess perceptions of sexism and adapted into Turkish by Sakallı-Uğurlu (2002). The scale consists of 22 items rated on a 6-point Likert scale (1 = strongly disagree, 6 = strongly agree) and includes two subscales: hostile sexism and benevolent sexism. Hostile sexism reflects negative attitudes and discriminatory behaviors toward women, emphasizing their inferiority and weakness. Benevolent sexism involves seemingly positive but patronizing attitudes based on patriarchal values, such as the belief that women should be protected and cherished. Although conceptually distinct, both dimensions contribute to the persistence of gender inequality. Higher scores indicate higher levels of hostile or benevolent sexism.

  3. Psychological Distress Level

    Time frame: From enrollment to the end of treatment at 6 weeks

    The Depression Anxiety Stress Scales (DASS) were developed by Lovibond and Lovibond (1995) to assess three components of negative emotional states: depression, anxiety, and stress. The original scale includes 42 items rated on a 4-point Likert scale (0 = Did not apply to me at all, 3 = Applied to me very much). The short version, DASS-21, was developed by Antony et al. (1998) and has been shown to be a valid and reliable tool. The Turkish adaptation of DASS-21 was conducted by Sarıçam (2018). The scale does not produce a total score; instead, each subscale is scored separately, with scores ranging from 0 to 21. Higher scores indicate higher levels of depression, anxiety, or stress in the corresponding subscale.

Sponsors and collaborators

Lead sponsor

Yuzuncu Yil University

Other

Registry information

Official study title

Effect of Gender-Based Microaggression Awareness and Prevention Psychoeducation Program on Gender Role Attitudes and Gender Role Stress of Female University Students

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 13, 2025
Registry last updated
Aug 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.